all report title image

CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Critical Limb Ischemia Treatment Market, By Drugs (Antihypertensive Agents, Antiplatelet Drugs, Antithrombotic Agents, Lipid-lowering Agents, and Others), By Route of administration (Oral and Parentral), By End User (Hospitals, Specialty Clinics , Ambulatory Surgery Centers, Nursing Homes, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Jul 2024
  • Code : CMI7115
  • Pages :140
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Critical Limb Ischemia Treatment Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Growing Number of Smokers

The growing number of smokers around the world is having a significant impact on the critical limb ischemia treatment market. As smoking is one of the major risk factors that can lead to peripheral artery disease (PAD) and critical limb ischemia, the rising prevalence of smoking will fuel the need for effective treatment options for this condition. PAD occurs when arteries in the legs or arms become narrowed due to buildup of fat, cholesterol, calcium or other substances over many years of smoking. Smoking constricts the blood vessels and reduces blood flow to arms and legs. It damages the inner lining of arteries and promotes formation of blood clots. All of these smoking-related effects increase the chances of developing critical limb ischemia, which is the most severe form of PAD that occurs when limbs do not receive adequate blood flow. According to recent data from the World Health Organization, In July 2023 approx one in five adults smoke tobacco on a daily basis globally. While smoking rates are declining in high-income countries, they are still elevated and rising in many low and middle-income countries. Every year over 8 million people die due to tobacco use. If current trends continue, tobacco is expected to kill more than 1 billion people globally in the 21st century. The growth in the overall number of smokers indicates that more people will develop critical limb ischemia due to PAD in the coming years due to prolonged smoking.

Key Players Insights
  • Medtronic plc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Cook Medical Inc.
  • Cardiovascular Systems, Inc.
  • Philips Healthcare
  • B. Braun Melsungen AG
  • Terumo Corporation
  • Biotronik SE & Co. KG
  • Cordis Corporation
  • Smith & Nephew plc
  • Stryker Corporation
  • AngioDynamics, Inc.
  • GE Healthcare
  • Sanofi S.A.
  • AstraZeneca plc
  • Bristol-Myers Squibb Company

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.